MRVI Maravai LifeSciences Holdings, Inc.
MRVI Maravai LifeSciences Holdings, Inc.
Healthcare · Biotechnology
Market read
POC $3.55 · VWAP $5.41 · +35.3% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Coverage
1 watchlist
MRVI Price Structure
Loading timeframes…
Peers
Every watchlist MRVI belongs to, members best 30-day change first — MRVI highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@monster-discoveries
Against street estimates
How MRVI's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. A consensus out of line with the name's earlier estimates (opposite sign to all of them and over 3x their size) is not graded. EPS only.
News (last pull)
Headlines about MRVI from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 20 days ago · Oct 3
- Maravai LifeSciences Holdings Inc (MRVI) (Q2 2026) Earnings Call
- Maravai LifeSciences Holdings, Inc. (MRVI)
- Maravai Lifesciences Holdings Stock Price Forecast. Should You Buy MRVI?
- Maravai Lifesciences Holdings, Inc. (MRVI) 10-Q Quarterly Report August 2026
- Maravai Lifesciences Holdings Inc Stock Price Today | NASDAQ: MRVI Live - Investing.com
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
MRVI research tape
9 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.